Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Tesetaxel Administered Once Every 21 Days to Japanese Subjects With Advanced Solid Tumors

NCT01337310 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.

NCT NCT01337310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01337310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Tesetaxel Administered Once Every 21 Days to Japanese Subjects With Advanced Solid Tumors
Lead sponsor
Genta Incorporated
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2011
Completion date
September 30, 2012
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors